The evaluations of subjects who endorsed only one abuse item supported the general conclusions noted for the data reported in
+Table 1. Regarding age, group C (mean=35.0 years, SD=10.9) and group B (mean=29.3 years, SD=4.5) were younger than group A (mean=38.4 years, SD=14.3) and group E (mean=40.1 years, SD=14.96) (F=7.97, df=3, 2140, p<0.001), with post hoc analyses revealing differences for A versus B, B versus C, and B versus E. More years of schooling were reported for group A (mean=13.4, SD=2.1) and group C (mean=13.8, SD=2.0), compared to group B (mean=12.1, SD=1.88) and group E (mean=13.2, SD=2.14) (F=7.45, df=3, 2439, p<0.001), with post hoc differences for A versus B, B versus C, and B versus E. The proportions of women were lower for groups A (76.9%), C (51.2%), and E (71.1%), compared to group B (91.7%) (χ
2=131.59, df=3, p<0.001), with post hoc analyses supporting differences for A versus C, B versus C, and C versus E. Ethnic differences across groups were significant overall (χ
2=56.19, df=3, p<0.001), reflecting a higher proportion of Caucasians in group C (87.2%), compared with 66.7%–73.7% in the remaining groups, with significant post hoc differences between group C and the remaining groups. Regarding baseline alcohol use, all parameters continued to support the lowest rates of alcohol problems in group A (group A: mean=0.9, SD=1.4; group B: mean=4.3, SD=2.2; group C: mean=3.3, SD=1.6; and group E: mean=3.5, SD=1.5) (F=400.02, df=3, 2440, p<0.005), with significant post hoc differentials for group A versus each other group, as well as for B versus C and B versus E. A similar differential was seen for maximum number of drinks in 24 hours (group A: mean=6.6, SD=5.8; group B: mean=11.8, SD=7.0; group C: mean=13.1, SD=7.7; and group E: mean=13.1, SD=9.9) (F=146.70, df=3, 2341, p<0.001), but post hoc tests supported only the differences between group A and each of the remaining groups. Values for history of drug intake were also lowest for group A overall, and post hoc tests revealed that the only significant additional differential occurred for cocaine use, reported by 12.3% of group A, 58.3% of group B, 35.6% of group C, and 24.4% of group E. A post hoc difference was noted for group B versus group E.